PubMed · 2009 · 36 citations · 8 references
ComputingCardiologyHealth InformaticsClinical Decision SupportClinical InformaticsDisease PreventionCardiovascular DiseaseCardiovascular Disease PreventionClinical Decision Support SystemsCoronary Artery DiseaseDyslipidemia ManagementLipid-lowering TherapyClinical Decision Support System ImplementationClinical Guidelines AdherenceCoronary Artery Disease PharmacotherapyDyslipidemia ScreeningDyslipidemia SurveillanceLow-density Lipoprotein Cholesterol MeasurementLow-density Lipoprotein ParticlesSecondary Prevention Of Dyslipidemia
BACKGROUND: Dyslipidemia remains underdiagnosed and undertreated in patients with coronary artery disease. The Computer-based Clinical Decision Support System provides an opportunity t close these gaps. OBJECTIVES: To study the impact of computerized intervention on secondary prevention of CAD. METHODS: The CDSS was programmed to automatically detect patients with CAD and to evaluate the availability of an updated lipoprotein profile and treatment with lipid-lowering drugs. The program produced automatic computer-generated monitoring and treatment recommendations. Adjusted primary clinics were randomly assigned to intervention (n=56) or standard care arms (n=56). Reminders were mailed to the primary medical teams in the intervention arm every 4 months updating them with current lipid levels and recommendations for further treatment. Compliance and lipid levels were monitored. The study group comprised all patients with CAD who were alive at least 3 months after hospitalization. RESULTS: Follow-up was available for 7448 patients (median 19.8 months, range 6-36 months). Overall, 51.7% of patients were adequately screened, and 55.7% of patients were compliant with treatment to lower lipid level. In patients with initial low density lipoprotein >120 mg/dl, a significant decrease in LDL levels was observed in both arms, but was more pronounced in the intervention arm: 121.9 +/- 34.2 vs. 124.3 +/- 34.6 mg/dl (P < 0.02). A significantly lower rate of cardiac rehospitalizations was documented in patients who were adequately treated with lipid-lowering drugs, 37% vs. 40.9% (P < 0.001). CONCLUSIONS: This initial assessment of our data represent a real-world snapshot where physicians and CAD patients often do not adhere to clinical guidelines, presenting a major obstacle to implementing effective secondary prevention. Our automatic computerized reminders system substantially facilitates adherence to guidelines and supports wide-range implementation.
8
Long-term Persistence in Use of Statin Therapy in Elderly Patients
Joshua S. Benner · JAMA · 2002 · 1.2K citations
Persistence of Use of Lipid-Lowering Medications
Jerry Avorn, Johanne Monette, Anne Sophie Lacour et al. · JAMA · 1998 · 639 citations
Secondary prevention in coronary heart disease: baseline survey of provision in general practice
Neil Campbell, J. Thain, H G. Deans et al. · BMJ · 1998 · 236 citations · Full text